To further explore the association between NAT10 expression and liver metastasis in GC, we performed immunohistochemical (IHC) staining on a tissue microarray (TMA) containing 75 primary tumor samples (cohort 1) from GC patients with liver metastasis (n = 23) or without liver metastasis (n = 52). The gene discussed is NAT10; the disease is gastric cancer.